Fragasso Financial Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Fragasso Financial Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-4,156	Closed	-$223K	–	79
2014 Q3	$223K	Buy	4,156 +38	+0.9%	+$2.01K	0.17%	72
2014 Q2	$216K	Sell	4,118 -6,695	-62%	-$342K	0.19%	66
2014 Q1	$571K	Sell	10,813 -40	-0.4%	-$1.85K	0.59%	44
2013 Q4	$435K	Buy	+10,853	New	+$427K	0.39%	48

Other funds holding TEVA

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fragasso Financial Advisors's TEVA Position: Q4 2014 in Review

Fragasso Financial Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2014, closing a stake of 4,156 shares — an estimated $223K sold.

Fragasso Financial Advisors first reported a position in TEVA in Q4 2013 and held it in 4 quarters. The position peaked at $571K in Q1 2014. 822 funds tracked by Wall St. Rank hold TEVA as of Q4 2014.

Fragasso Financial Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2014 after selling out during the quarter.
Fragasso Financial Advisors sold 4,156 Teva Pharmaceutical Industries Limited shares in Q4 2014, an estimated $223K.
Fragasso Financial Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q4 2013 and held it in 4 quarters.
Fragasso Financial Advisors's Teva Pharmaceutical Industries Limited position peaked at $571K in Q1 2014.
822 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2014.

Based on Fragasso Financial Advisors's 13F filing for Q4 2014, filed 21 Jan 2015.